Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC).
Kehmann L, Berres ML, Gonzalez-Carmona M, Modest DP, Mohr R, Wree A, Venerito M, Strassburg C, Keitel V, Trautwein C, Luedde T, Roderburg C. Kehmann L, et al. Among authors: modest dp. BMC Cancer. 2023 May 22;23(1):470. doi: 10.1186/s12885-023-10972-6. BMC Cancer. 2023. PMID: 37217885 Free PMC article.
Inhibition of Vascular Endothelial Growth Factor Protects against the Development of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome in Wild-Type but Not in CD39-Null Mice.
Knitter S, Duwe G, Beierle AS, Pesthy S, Ritschl PV, Hillebrandt KH, Arnold A, Malinka T, Modest DP, Bahra M, Pratschke J, Sauer IM, Schmelzle M, Andreou A. Knitter S, et al. Among authors: modest dp. Cancers (Basel). 2022 Dec 5;14(23):5992. doi: 10.3390/cancers14235992. Cancers (Basel). 2022. PMID: 36497474 Free PMC article.
BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancer.
Ambrosini M, Tougeron D, Modest D, Guimbaud R, Kopetz S, Decraecker M, Kim S, Coutzac C, Perkins G, Alouani E, Marmorino F, Pernot S, Sinicrope FA, Elez E, Parent P, Cremolini C, Pietrantonio F, Lonardi S, Gallois C, Taieb J. Ambrosini M, et al. Eur J Cancer. 2024 Oct;210:114290. doi: 10.1016/j.ejca.2024.114290. Epub 2024 Aug 22. Eur J Cancer. 2024. PMID: 39216175
Correction: Is interval chemotherapy safe and does it improve the outcome of patients with colorectal liver metastases undergoing multimodal two-stage hepatectomy? - A systematic literature review.
Raschzok N, Moosburner S, Blank M, Krenzien F, Lurje G, Schöning W, Sauer IM, Pratschke J, Modest DP, Kurreck A. Raschzok N, et al. Among authors: modest dp. BMC Cancer. 2024 Nov 11;24(1):1382. doi: 10.1186/s12885-024-13152-2. BMC Cancer. 2024. PMID: 39528976 Free PMC article. No abstract available.
Body composition is associated with disease aetiology and prognosis in patients undergoing resection of intrahepatic cholangiocarcinoma.
Lurje I, Uluk D, Pavicevic S, Phan MD, Eurich D, Fehrenbach U, Geisel D, Auer TA, Pelzer U, Modest DP, Raschzok N, Sauer IM, Schöning W, Tacke F, Pratschke J, Lurje G. Lurje I, et al. Among authors: modest dp. Cancer Med. 2023 Sep;12(17):17569-17580. doi: 10.1002/cam4.6374. Epub 2023 Jul 26. Cancer Med. 2023. PMID: 37496321 Free PMC article.
Viscoelastic properties of colorectal liver metastases reflect tumour cell viability.
Skrip LM, Moosburner S, Tang P, Guo J, Görner S, Tzschätzsch H, Brüggemann K, Walter KA, Hosse C, Fehrenbach U, Arnold A, Modest D, Krenzien F, Schöning W, Malinka T, Pratschke J, Papke B, Käs JA, Sack I, Sauer IM, Hillebrandt KH. Skrip LM, et al. J Transl Med. 2024 Aug 16;22(1):774. doi: 10.1186/s12967-024-05559-z. J Transl Med. 2024. PMID: 39152426 Free PMC article.
167 results